Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × palbociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasm Metastasis 11 Neoplasms 8 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Breast Diseases 4 Sarcoma 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Liposarcoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumors 2 Advanced Breast Cancer 2 von Hippel-Lindau Disease 1 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Venous Thromboembolism 1

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡